project id: TCGA-BLCA; case submitter id: TCGA-DK-AA6U; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.13; rna integrity number: 7.7; age at index: 64; days to birth: -23611; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1949; age at diagnosis: 23611; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 578.0; icd 10 code: C67.2; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lateral wall of bladder; synchronous malignancy: No; tissue or organ of origin: Lateral wall of bladder; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; cigarettes per day: 0.821917808219178; pack years smoked: 15.0; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 172; initial weight: 30.0; sample id: ccfee146-e91d-413a-8466-33efb4502990; sample submitter id: TCGA-DK-AA6U-01A; portion id: 4285ff8a-9440-4a8f-91df-c2055eee7c1d; portion submitter id: TCGA-DK-AA6U-01A-11; slide id: 17c982e2-e810-4f04-853c-582dc30742da; slide submitter id: TCGA-DK-AA6U-01A-01-TS1; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; section location: TOP;